Evidence map›Paper›PMID 38353529›Full record

ArticleJournal of bacteriology2024

An adapted method for Cas9-mediated editing reveals the species-specific role of β-glucoside utilization driving competition between

Éva D H Almási, Nele Knischewski, Lisa Osbelt, Uthayakumar Muthukumarasamy, Youssef El Mouali, Elena Vialetto, Chase L Beisel, Till Strowig

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Development of modular expression across phylogenetically distinct diazotrophs.Journal of industrial microbiology & biotechnology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Éva D H AlmásiHelmholtz Centre for Infection Research (HZI), Braunschweig, Germany.ORCID 0000-0001-5042-5478
Nele KnischewskiHelmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
Lisa OsbeltHelmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
Uthayakumar MuthukumarasamyHelmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
Youssef El MoualiHelmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
Elena VialettoHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Chase L BeiselHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Till StrowigHelmholtz Centre for Infection Research (HZI), Braunschweig, Germany.ORCID 0000-0003-0185-1459
Helmholtz Centre for Infection Research · DEGerman Center for Infection Research · DEUniversity of Würzburg · DE

Funding

Bundesministerium für Bildung und Forschung (BMBF) 01KI1824Bundesministerium für Bildung und Forschung (BMBF) 01KI2131
6 · The paper itself

Abstract

Cas9-based gene editing tools have revolutionized genetics, enabling the fast and precise manipulation of diverse bacterial species. However, widely applicable genetic tools for non-model gut bacteria are unavailable. Here, we present a two-plasmid Cas9-based system designed for gene deletion and knock-in complementation in three members of the IMPORTANCE: Cas9-based gene editing tools have revolutionized bacterial genetics, yet, their application to non-model gut bacteria is frequently hampered by various limitations. We utilized a two-plasmid Cas9-based system designed for gene deletion in

Indexed as

CRISPR-Cas SystemsKlebsiellaKlebsiella pneumoniaeCRISPR/Cas9gene editingKlebsiella oxytocamicrobial competition

Identifiers

PMID38353529
PMCPMC10955844
OpenAlexW4391811911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.